Proteomic Analysis Reveals Physiological Activities of Aβ Peptide for Alzheimer’s Disease
Open Access
- 30 July 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8336
Abstract
With the rapid progress in deciphering the pathogenesis of Alzheimer’s disease (AD), it has been widely accepted that the accumulation of misfolded amyloid β (Aβ) in the brain could cause the neurodegeneration in AD. Although much evidence demonstrates the neurotoxicity of Aβ, the role of Aβ in the nervous system are complex. However, more comprehensive studies are needed to understand the physiological effect of Aβ40 monomers in depth. To explore the physiological mechanism of Aβ, we employed mass spectrometry to investigate the altered proteomic events induced by a lower submicromolar concentration of Aβ. Human neuroblastoma SH-SY5Y cells were exposed to five different concentrations of Aβ1-40 monomers and collected at four time points. The proteomic analysis revealed the time–course behavior of proteins involved in biological processes, such as RNA splicing, nuclear transport and protein localization. Further biological studies indicated that Aβ40 monomers may activate PI3K/AKT signaling to regulate p-Tau, Ezrin and MAP2. These three proteins are associated with dendritic morphogenesis, neuronal polarity, synaptogenesis, axon establishment and axon elongation. Moreover, Aβ40 monomers may regulate their physiological forms by inhibiting the expression of BACE1 and APP via activation of the ERK1/2 pathway. A comprehensive exploration of pathological and physiological mechanisms of Aβ is beneficial for exploring novel treatment.Keywords
Funding Information
- National Natural Science Foundation of China (21703163, 52372271, 104972024KFYjc0077)
- Fundamental Research Funds for the Central Universities (21703163, 52372271, 104972024KFYjc0077)
This publication has 41 references indexed in Scilit:
- Long-term depression links amyloid-β to the pathological hyperphosphorylation of tauCell Reports, 2021
- Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid β-Protein-Induced Synapse Loss in Alzheimer’s DiseaseCell Reports, 2020
- The physical approximation of APP and BACE‐1: A key event in alzheimer's disease pathogenesisDevelopmental Neurobiology, 2017
- The fate of the brain cholinergic neurons in neurodegenerative diseasesBrain Research, 2017
- The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemiaMetabolism, 2017
- Lessons from a Failed γ-Secretase Alzheimer TrialCell, 2014
- Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain TissueCell, 2013
- Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's DiseaseMolecular Neurobiology, 2012
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse ModelsCell, 2010
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994